{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:24:28Z","timestamp":1782221068175,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"TranCYST","award":["317246"],"award-info":[{"award-number":["317246"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0654-y","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T09:40:28Z","timestamp":1500284428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Temporal and geographical external validation study and extension of the Mayo Clinic prediction model to predict eGFR in the younger population of Swiss ADPKD patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Laura","family":"Girardat-Rotar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo A.","family":"Puhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-5605","authenticated-orcid":false,"given":"Andreas L.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"issue":"5","key":"654_CR1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","volume":"67","author":"FT Chebib","year":"2016","unstructured":"Chebib FT, Torres VE. Autosomal dominant polycystic kidney disease: Core curriculum 2016. Am J Kidney Dis. 2016;67(5):792\u2013810.","journal-title":"Am J Kidney Dis"},{"key":"654_CR2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12916-015-0493-2","volume":"13","author":"MA Puhan","year":"2015","unstructured":"Puhan MA, Yu T, Stegeman I, Varadhan R, Singh S, Boyd CM. Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer. BMC Med. 2015;13:250.","journal-title":"BMC Med"},{"key":"654_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12916-015-0398-0","volume":"13","author":"MA Puhan","year":"2015","unstructured":"Puhan MA, Yu T, Boyd CM, Ter Riet G. Quantitative benefit-harm assessment for setting research priorities: the example of roflumilast for patients with COPD. BMC Med. 2015;13:157.","journal-title":"BMC Med"},{"issue":"9981","key":"654_CR4","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","volume":"385","author":"AC Ong","year":"2015","unstructured":"Ong AC, Devuyst O, Knebelmann B, Walz G. Diseases E-EWGfIK: autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet. 2015;385(9981):1993\u20132002.","journal-title":"Lancet"},{"issue":"9147","key":"654_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer N. V Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, san Millan JL, Torra R, Breuning M, ravine D: comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 study group. Lancet. 1999;353(9147):103\u20137.","journal-title":"Lancet"},{"issue":"6","key":"654_CR6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013;24(6):1006\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"654_CR7","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318.","journal-title":"N Engl J Med"},{"issue":"1","key":"654_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015;88(1):17\u201327.","journal-title":"Kidney Int"},{"key":"654_CR9","unstructured":"Agency. EM: Jinarc International non-proprietary name: tolvaptan. In.; 2015."},{"key":"654_CR10","volume-title":"Clinical prediction models a practical approach to development, validation, and updating","author":"EW Steyerberg","year":"2009","unstructured":"Steyerberg EW. Clinical prediction models a practical approach to development, validation, and updating. New York, NY: Springer; 2009."},{"issue":"2","key":"654_CR11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneph.2009.214","volume":"6","author":"KT Bae","year":"2010","unstructured":"Bae KT, Grantham JJ. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010;6(2):96\u2013106.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"654_CR12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ, Mrug M, et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015;26(1):160\u201372.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"654_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrneph.2014.132","volume":"10","author":"E Cornec-Le Gall","year":"2014","unstructured":"Cornec-Le Gall E, Le Meur Y. Polycystic kidney disease: kidney volume--a crystal ball for ADPKD prognosis? Nat Rev Nephrol. 2014;10(9):485\u20136.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"654_CR14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","volume":"31","author":"RT Gansevoort","year":"2016","unstructured":"Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G, Covic A, Devuyst O, Drechsler C, Eckardt KU, Emma F, et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA working groups on inherited kidney disorders and European renal best practice. Nephrol Dial Transplant. 2016;31(3):337\u201348.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"654_CR15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363(9):820\u20139.","journal-title":"N Engl J Med"},{"key":"654_CR16","unstructured":"Shagun Raina FK: Standard Operating Procedure: MRI Volumetry for ADPKD Registry. In., vol. 001: Department of Nephrology, University Hospital Zurich; 2007."},{"issue":"4","key":"654_CR17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123555","volume":"10","author":"K Petzold","year":"2015","unstructured":"Petzold K, Poster D, Krauer F, Spanaus K, Andreisek G, Nguyen-Kim TD, Pavik I, Ho TA, Serra AL, Rotar L. Urinary biomarkers at early ADPKD disease stage. PLoS One. 2015;10(4):e0123555.","journal-title":"PLoS One"},{"issue":"9","key":"654_CR18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"8476","key":"654_CR19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307\u201310.","journal-title":"Lancet"},{"issue":"477","key":"654_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1198\/016214506000001437","volume":"102","author":"T Gneiting","year":"2007","unstructured":"Gneiting T, Raftery AE. Strictly proper scoring rules, prediction, and estimation. J Am Stat Assoc. 2007;102(477):359\u201378.","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"654_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1541-0420.2011.01621.x","volume":"68","author":"J Braun","year":"2012","unstructured":"Braun J, Held L, Ledergerber B. Predictive cross-validation for the choice of linear mixed-effects models with application to data from the Swiss HIV cohort study. Biometrics. 2012;68(1):53\u201361.","journal-title":"Biometrics"},{"key":"654_CR22","unstructured":"Haile SR: Multiple Imputation using STATA. In., vol. Version 1.1; 2016."},{"issue":"4","key":"654_CR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"issue":"5","key":"654_CR24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.06.017","volume":"66","author":"EM Spithoven","year":"2015","unstructured":"Spithoven EM, van Gastel MD, Messchendorp AL, Casteleijn NF, Drenth JP, Gaillard CA, de Fijter JW, Meijer E, Peters DJ, Kappert P, et al. Estimation of total kidney volume in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2015;66(5):792\u2013801.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"654_CR25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jclinepi.2014.11.010","volume":"68","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. J Clin Epidemiol. 2015;68(2):134\u201343.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T09:40:57Z","timestamp":1500284457000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0654-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0654-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]},"article-number":"241"}}